Azmarda (Sacubitril Valsartan)

medicaldialogues

posted on 2 years ago — updated on 1 second ago

166
views

Azmarda Sacubitril/ Valsartan is indicated in adults with long-term heart failure who have symptoms of the disease to reduce the risk of cardiovascular death and hospitalization for heart failure in patients with chronic heart failure (NYHA Class II-IV) and reduced ejection fraction. Read more at https://medicaldialogues.in/partner/jbcpl/azmarda-sacubitril-valsartan

medicaldialogues

Medical Dialogues is a new way of medical journalism in India. Medical Dialogues (medicaldialogues.in and all its subdomains) is owned and operated by Minerva Medical Treatment Pvt Ltd and was founded in 2015 by health researcher Meghna A Singhania and Cardiologist Dr. Prem Aggarwal with an aim to update and empower medical professionals of India